What medications are used for long-term treatment of urinary tract infections (UTIs) without antibiotics?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Non-Antibiotic Medications for Long-Term Treatment of Urinary Tract Infections

For long-term treatment of urinary tract infections without antibiotics, methenamine hippurate (1g twice daily) is the most effective non-antibiotic medication, followed by vaginal estrogen in postmenopausal women and cranberry products containing 36mg of proanthocyanidin. 1

First-Line Non-Antibiotic Options

Methenamine Hippurate

  • FDA-approved for prophylactic or suppressive treatment of frequently recurring UTIs when long-term therapy is considered necessary 2
  • Recommended dosage: 1g twice daily 1
  • Works by releasing formaldehyde in acidic urine, creating a bactericidal effect 1
  • Most effective in patients without incontinence and with fully functional bladders 1
  • Should only be used after eradication of the initial infection with appropriate antimicrobial agents 2
  • Has low risk of adverse events and doesn't contribute to antibiotic resistance 1
  • Long-term studies show it reduces UTI recurrence by approximately two-thirds compared to pre-treatment periods 3

Vaginal Estrogen (for postmenopausal women)

  • Clear recommendation with strong evidence from 30 RCTs and 1 large retrospective observational study 1
  • Available as vaginal rings, inserts, or creams 1
  • Helps restore vaginal microbiome, reduces vaginal atrophy, and decreases UTI frequency 1
  • Minimal systemic absorption with no concerning safety signals regarding stroke, venous thromboembolism, breast cancer, colorectal cancer, or endometrial cancer 1
  • Women with history of estrogen-related malignancies should discuss risks/benefits with their healthcare team 1
  • Oral estrogen is NOT effective for UTI prevention 1

Cranberry Products

  • Clear recommendation for products containing proanthocyanidin levels of 36mg 1
  • Effective in reducing recurrent UTIs in women, children, and individuals susceptible to UTIs 1
  • Evidence shows cranberry products reduce UTI risk by approximately 26% 1
  • Insufficient data for older people, those with bladder emptying problems, or pregnant women 1

Second-Line Non-Antibiotic Options

Increased Water Intake

  • Additional 1.5L of water daily may decrease UTI frequency 1
  • Shown to decrease UTIs in one RCT among healthy women 1
  • Low-risk intervention that can be reasonably offered to healthy women with recurrent UTIs 1

Probiotics

  • Evidence is mixed and inconclusive 1
  • Studies are heterogeneous regarding patient populations, specific probiotic strains, routes of administration, and study design 1
  • Some evidence suggests certain Lactobacillus strains may be beneficial, particularly vaginal suppositories containing L. crispatus CTV-05 or combination of L. rhamnosus GR-1 + L. fermentum B-54 1
  • Currently no formal recommendation due to inconsistent evidence 1

Monitoring and Follow-Up

  • Patients should seek immediate medical attention if symptoms don't resolve within 4 weeks after treatment completion, recur within 2 weeks, or if they develop signs of pyelonephritis 4
  • For patients whose symptoms don't resolve by the end of treatment or recur within 2 weeks, a urine culture with antimicrobial susceptibility testing should be performed 4
  • Routine post-treatment urinalysis or urine cultures are NOT indicated for asymptomatic patients 4

Special Considerations

  • Methenamine hippurate is most effective as prophylaxis after achieving abacteriuria, rather than for treating established infections 3
  • For established infections, appropriate antibiotics should be used first, followed by methenamine hippurate for prophylaxis 3
  • No evidence of urinary calculus formation, deterioration of renal function, or hematological changes with long-term methenamine hippurate use 3
  • The growing problem of antibiotic resistance makes non-antibiotic approaches increasingly important 5, 6, 7
  • Patients with risk factors for complicated UTI require closer monitoring and potentially different management approaches 4

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.